News | March 19, 2012

National Physical Laboratory Purchases Nucletron's Brachytherapy Afterloader

March 19, 2012 -- The National Physical Laboratory (NPL), the United Kingdom's national measurement institute, recently purchased a Flexitron afterloader from Nucletron, an Elekta company. NPL will continue to offer its brachytherapy calibration service with the new afterloader and ensure source calibrations in radiotherapy centers remain traceable to NPL's primary standard.

"We chose Flexitron because it is a highly advanced brachytherapy platform that met all our requirements, offering the accuracy necessary to achieve the scientific excellence we strive for," says Thorsten Sander, senior research scientist at NPL. "Flexitron also provides us the opportunity to collaborate in the development of new technologies, to expand brachytherapy products and applications."

Nucletron and NPL have collaborated since 1992.

Flexitron is an advanced afterloader that takes brachytherapy to a new level. With robust safety features and flexible 40-channel configuration, Flexitron is designed to treat both very small and very large tumors without reconnections in intuitive 1 mm steps.

Accurate determination of source positions is simplified and reliability is enhanced with Nucletron's zero reference source positioning system, which defines dwell positions in absolute values. This significantly reduces the chance of human error; no additional measures or manual recalculations are required. Procedures take less time and are easier to check. Flexitron patented source drives are more precise and
durable than ever, providing reliable treatment from year to year.

For more information:,

Related Content

Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Prostate Brachytherapy Shows Low Incidence of Short-Term Complications
News | Brachytherapy Systems | October 31, 2018
A new analysis of nearly 600 men receiving brachytherapy for prostate cancer shows overall procedure-related...
News | Brachytherapy Systems, Women's Healthcare | October 25, 2018
iCAD Inc. announced new clinical research demonstrating positive outcomes supporting the use of the Xoft Axxent...
Xoft Electronic Brachytherapy System Effective Long-Term for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 02, 2018
Breast cancer recurrence rates for patients treated with the Xoft Axxent Electronic Brachytherapy (eBx) System that...
Varian Showcases Advanced Cancer Care Solutions at AAPM 2018
News | Radiation Therapy | July 27, 2018
Varian announced it will be showcasing its advanced cancer care solutions, including a new version of the Eclipse...
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...